<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7200043\results\search\disease\results.xml">
  <result pre="are associated with high viraemia, liver damage, renal failure, bleeding," exact="encephalopathy" post="and a shock-like syndrome.4 7–10 Health systems in areas"/>
  <result pre="ribavirin are only available for different dosing regimens used for" exact="hepatitis" post="C.25 The multiple dose half-life of ribavirin is estimated"/>
  <result pre="al.Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic" exact="hepatitis" post="C genotype 1 infection. Aaps J2012;14:571–80. 10.1208/s12248-012-9368-z22639111 30collab: CMRCMaximum"/>
  <result pre="exploratory approach to optimize the dosing of Peg-IFN/RBV in cirrhotic" exact="hepatitis" post="C patients treated with triple therapy. CPT Pharmacometrics Syst"/>
 </snippets>
</snippetsTree>
